Fredun Pharmaceuticals Reschedules Investor Meeting to March 25, 2026 Virtual Format
Fredun Pharmaceuticals Limited has rescheduled its investor/analyst meeting from March 18 to March 25, 2026 at 12:00 PM, transitioning from a physical Mumbai meeting to a virtual format. The company has notified BSE Limited under Regulation 30 compliance, with Managing Director Fredun Nariman Medhora digitally signing the official communication dated March 21, 2026.